Product Description: FAAH-IN-6 (compound 21d) is a potent, orally active and cross the blood-brain barrier fatty acid amide hydrolase (FAAH) inhibitor with IC50s of 0.72, 0.28 nM for hFAAH, rFAAH, respectively. FAAH-IN-6 shows dose-dependent analgesic efficacy in animal models of both neuropathic and inflammatory pain[1].
Applications: Neuroscience-Neuromodulation
Formula: C19H17F2N7O
References: [1]Kono M, et al. Design, synthesis, and biological evaluation of a series of piperazine ureas as fatty acid amide hydrolase inhibitors. Bioorg Med Chem. 2014 Feb 15;22(4):1468-78.
CAS Number: 1143578-94-2
Molecular Weight: 397.38
Compound Purity: 99.70
Research Area: Neurological Disease
Solubility: DMSO : 100 mg/mL (ultrasonic)
Target: FAAH